C.L. Ferguson

894 total citations
14 papers, 89 citations indexed

About

C.L. Ferguson is a scholar working on Oncology, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, C.L. Ferguson has authored 14 papers receiving a total of 89 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Obstetrics and Gynecology and 3 papers in Surgery. Recurrent topics in C.L. Ferguson's work include Endometrial and Cervical Cancer Treatments (4 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). C.L. Ferguson is often cited by papers focused on Endometrial and Cervical Cancer Treatments (4 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). C.L. Ferguson collaborates with scholars based in United States, Canada and South Korea. C.L. Ferguson's co-authors include Brian D. Kavanagh, David Huang, Jiandong Lu, Stephen Lutz, Guilherme Cantuaria, Ann H. Klopp, Anamaria R. Yeung, Yong Bae Kim, Krzysztof Gil and Lari Wenzel and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Journal of Hepatology.

In The Last Decade

C.L. Ferguson

11 papers receiving 88 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.L. Ferguson United States 5 32 32 28 27 18 14 89
Spencer Thompson United States 6 48 1.5× 32 1.0× 18 0.6× 20 0.7× 20 1.1× 15 106
Sara Zakem United States 5 31 1.0× 12 0.4× 40 1.4× 24 0.9× 7 0.4× 12 78
Desiree E. Doncals United States 5 65 2.0× 39 1.2× 29 1.0× 23 0.9× 24 1.3× 12 99
Dina Najjari-Jamal Spain 5 39 1.2× 31 1.0× 11 0.4× 17 0.6× 13 0.7× 13 72
Myriam Bouchard Canada 5 31 1.0× 17 0.5× 94 3.4× 42 1.6× 13 0.7× 8 124
Katarina Majerčáková Spain 6 43 1.3× 52 1.6× 25 0.9× 9 0.3× 14 0.8× 15 132
K. De Winter Netherlands 5 37 1.2× 73 2.3× 12 0.4× 32 1.2× 21 1.2× 5 109
Dominique Rash United States 8 76 2.4× 92 2.9× 35 1.3× 32 1.2× 34 1.9× 22 178
Stephanie Kuku United Kingdom 3 23 0.7× 39 1.2× 15 0.5× 17 0.6× 8 0.4× 4 87
M. Panadés United Kingdom 5 21 0.7× 26 0.8× 22 0.8× 18 0.7× 19 1.1× 7 60

Countries citing papers authored by C.L. Ferguson

Since Specialization
Citations

This map shows the geographic impact of C.L. Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.L. Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.L. Ferguson more than expected).

Fields of papers citing papers by C.L. Ferguson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.L. Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.L. Ferguson. The network helps show where C.L. Ferguson may publish in the future.

Co-authorship network of co-authors of C.L. Ferguson

This figure shows the co-authorship network connecting the top 25 collaborators of C.L. Ferguson. A scholar is included among the top collaborators of C.L. Ferguson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.L. Ferguson. C.L. Ferguson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
McCartney, Erin M., Jacqui Richmond, Alan Wigg, et al.. (2024). Point-of-Care Testing for Hepatitis C in the Priority Settings of Mental Health, Prisons, and Drug and Alcohol Facilities—the PROMPt Study. Clinical Infectious Diseases. 79(4). 965–973. 4 indexed citations
2.
Konski, André, Snehal Deshmukh, Ann H. Klopp, et al.. (2023). Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203. Gynecologic Oncology. 175. 176–181. 1 indexed citations
3.
Ferguson, C.L., Erin M. McCartney, Jacqui Richmond, et al.. (2022). Point of care testing for hepatitis C in the priority settings of mental health, prisons and drug and alcohol facilities. Journal of Hepatology. 77. S228–S228.
4.
Yeung, Anamaria R., Ann H. Klopp, Krzysztof Gil, et al.. (2019). IMRT Improves Late Toxicity Compared to Conventional RT: An Update on NRG Oncology-RTOG 1203. International Journal of Radiation Oncology*Biology*Physics. 105(1). S50–S50. 10 indexed citations
5.
Jermoumi, M, et al.. (2018). Planning Target Volume Determination of Internal Mammary Nodes in Breast Cancer using 4DCT. International Journal of Radiation Oncology*Biology*Physics. 102(3). e544–e545. 1 indexed citations
6.
Rabatic, B.M., Kuang‐Hua Huang, Shou‐Ching Tang, et al.. (2016). Modern Demographics, Oncologic Outcomes, and Prognostic Factors in Women With Inflammatory Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). E49–E49. 2 indexed citations
7.
Rabatic, B.M., Edward M. Marchan, William Martin, et al.. (2016). Mediastinal germ cell tumors and development of secondary leukemia and solid tumors.. Journal of Clinical Oncology. 34(15_suppl). e16043–e16043. 1 indexed citations
8.
Klopp, Ann H., Anamaria R. Yeung, Krzysztof Gil, et al.. (2016). A Phase III Randomized Trial Comparing Patient-Reported Toxicity and Quality of Life (QOL) During Pelvic Intensity Modulated Radiation Therapy as Compared to Conventional Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 96(2). S3–S3. 27 indexed citations
9.
Rabatic, B.M., J. Kenneth Byrd, Morris D. Groves, et al.. (2016). Risk of Second Primary Malignancy in Head and Neck Cancer Patients: A Population-Based Study. International Journal of Radiation Oncology*Biology*Physics. 96(2). E392–E392. 4 indexed citations
10.
Marchan, Edward M., John R. Vender, Cargill H. Alleyne, et al.. (2016). The Role of Internationally Standardized Radiosurgery Treatment Parameters in Predicting Long-Term Trigeminal Neuralgia Outcomes. International Journal of Radiation Oncology*Biology*Physics. 96(2). S175–S176. 1 indexed citations
11.
Rabatic, B.M., et al.. (2015). Real Time Robot-Assisted Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Oncologic and Functional Outcomes. International Journal of Radiation Oncology*Biology*Physics. 93(3). E275–E275.
12.
Rabatic, B.M., et al.. (2015). Real Time Robot-Assisted Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Feasibility and Toxicity. International Journal of Radiation Oncology*Biology*Physics. 93(3). E274–E275.
13.
Lutz, Stephen, et al.. (1997). A retrospective quality of life analysis using the lung cancer symptom scale in patients treated with palliative radiotherapy for advanced nonsmal cell lung cancer. International Journal of Radiation Oncology*Biology*Physics. 37(1). 117–122. 33 indexed citations
14.
Sangster, Guillermo, et al.. (1984). Sequential methotrexate plus 5-FU in advanced breast and colorectal cancers: a phase II study.. PubMed. 68(3). 547–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026